Literature DB >> 27404878

Plant specific N-glycans do not have proven adverse effects in humans.

Yoseph Shaaltiel1, Yoram Tekoah1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27404878     DOI： 10.1038/nbt.3556

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  8 in total

Review 1.  Large-scale production of pharmaceutical proteins in plant cell culture-the Protalix experience.

Authors:  Yoram Tekoah; Avidor Shulman; Tali Kizhner; Ilya Ruderfer; Liat Fux; Yakir Nataf; Daniel Bartfeld; Tami Ariel; Svetlana Gingis-Velitski; Uri Hanania; Yoseph Shaaltiel
Journal:  Plant Biotechnol J       Date:  2015-06-23       Impact factor: 9.803

2.  Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose.

Authors:  Muriel Bardor; Christelle Faveeuw; Anne-Catherine Fitchette; Danièle Gilbert; Ludovic Galas; Francois Trottein; Loïc Faye; Patrice Lerouge
Journal:  Glycobiology       Date:  2002-12-17       Impact factor: 4.313

3.  GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.

Authors:  Leander Meuris; Francis Santens; Greg Elson; Nele Festjens; Morgane Boone; Anaëlle Dos Santos; Simon Devos; François Rousseau; Evelyn Plets; Erica Houthuys; Pauline Malinge; Giovanni Magistrelli; Laura Cons; Laurence Chatel; Bart Devreese; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

Review 4.  N-glycosylation of plant-produced recombinant proteins.

Authors:  Dirk Bosch; Alexandra Castilho; Andreas Loos; Arjen Schots; Herta Steinkellner
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 5.  The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disorders.

Authors:  A Broomfield; S A Jones; S M Hughes; B W Bigger
Journal:  J Inherit Metab Dis       Date:  2016-02-16       Impact factor: 4.982

6.  Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines.

Authors:  Brian J Ward; Nathalie Landry; Sonia Trépanier; Geneviève Mercier; Michèle Dargis; Manon Couture; Marc-André D'Aoust; Louis-P Vézina
Journal:  Vaccine       Date:  2014-09-19       Impact factor: 3.641

7.  Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds.

Authors:  Robin Piron; Francis Santens; Annelies De Paepe; Ann Depicker; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2015-11       Impact factor: 54.908

8.  Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza.

Authors:  Nathalie Landry; Brian J Ward; Sonia Trépanier; Emanuele Montomoli; Michèle Dargis; Giulia Lapini; Louis-P Vézina
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240
  8 in total
  22 in total

1.  Glyco-Engineering of Plant-Based Expression Systems.

Authors:  Rainer Fischer; Tanja Holland; Markus Sack; Stefan Schillberg; Eva Stoger; Richard M Twyman; Johannes F Buyel
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

2.  Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.

Authors:  Matthew Dent; Jonathan Hurtado; Amber M Paul; Haiyan Sun; Huafang Lai; Ming Yang; Adrian Esqueda; Fengwei Bai; Herta Steinkellner; Qiang Chen
Journal:  J Gen Virol       Date:  2016-10-20       Impact factor: 3.891

3.  An oxidation-resistant, recombinant alpha-1 antitrypsin produced in Nicotiana benthamiana.

Authors:  David Z Silberstein; Kalimuthu Karuppanan; Hnin Hnin Aung; Ching-Hsien Chen; Carroll E Cross; Karen A McDonald
Journal:  Free Radic Biol Med       Date:  2018-03-16       Impact factor: 7.376

4.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  Purification, characterization, and N-glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension cultures.

Authors:  Jasmine M Corbin; Muchena J Kailemia; C Linn Cadieux; Salem Alkanaimsh; Kalimuthu Karuppanan; Raymond L Rodriguez; Carlito B Lebrilla; Douglas M Cerasoli; Karen A McDonald; Somen Nandi
Journal:  Biotechnol Bioeng       Date:  2018-02-27       Impact factor: 4.530

6.  Development and Expression of Subunit Vaccines Against Viruses in Plants.

Authors:  Adrian Esqueda; Qiang Chen
Journal:  Methods Mol Biol       Date:  2021

7.  Technoeconomic analysis of semicontinuous bioreactor production of biopharmaceuticals in transgenic rice cell suspension cultures.

Authors:  Jasmine M Corbin; Matthew J McNulty; Kantharakorn Macharoen; Karen A McDonald; Somen Nandi
Journal:  Biotechnol Bioeng       Date:  2020-07-14       Impact factor: 4.395

8.  The B cell death function of obinutuzumab-HDEL produced in plant (Nicotiana benthamiana L.) is equivalent to obinutuzumab produced in CHO cells.

Authors:  Jin Won Lee; Woon Heo; Jinu Lee; Narae Jin; Sei Mee Yoon; Ki Youl Park; Eun Yu Kim; Woo Taek Kim; Joo Young Kim
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

9.  Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems-The taliglucerase alfa story.

Authors:  Bonita Rup; Sari Alon; Bat-Chen Amit-Cohen; Einat Brill Almon; Raul Chertkoff; Yoram Tekoah; Pauline M Rudd
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 10.  Development of Antibody Therapeutics against Flaviviruses.

Authors:  Haiyan Sun; Qiang Chen; Huafang Lai
Journal:  Int J Mol Sci       Date:  2017-12-25       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.